GSK
(LSE) GSK
GSK Financials at a Glance
Market Cap
$7.36T
Revenue (TTM)
$32.78B
Net Income (TTM)
$5.83B
EPS (TTM)
$142.38
P/E Ratio
12.76
Dividend
$66.00
Beta (Volatility)
0.01 (Low)
Dividend
$66.00
Beta (Volatility)
0.01 (Low)
Price
$1844.50
Volume
9,314,552
Open
$1858.00
Price
$1844.50
Volume
9,314,552
Open
$1858.00
Previous Close
$1844.50
Daily Range
$1841.00 - $1870.00
52-Week Range
$1315.00 - $2282.00
Dividend
$66.00
Beta (Volatility)
0.01 (Low)
Price
$1844.50
Volume
9,314,552
Open
$1858.00
Previous Close
$1844.50
Daily Range
$1841.00 - $1870.00
52-Week Range
$1315.00 - $2282.00
GSK News
Sex, Drugs, and China Woes
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Luke Miels, MBA
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GSK Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
22%
Net Income Margin
18%
Return on Equity
36%
Return on Capital
18%
Return on Assets
9%
Earnings Yield
7.84%
Dividend Yield
3.58%
Payout Ratio
44.52%
Stock Overview
Market Cap
$7.36T
Shares Outstanding
3.99B
Volume
9.31M
Avg. Volume
9.18M
Financials (TTM)
Gross Profit
$23.70B
Operating Income
$7.17B
EBITDA
$11.88B
Operating Cash Flow
$7.30B
Capital Expenditure
$1.35B
Free Cash Flow
$5.96B
Cash & ST Invst.
$3.16B
Total Debt
$17.72B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.63B
+1.5%
Gross Profit
$5.75B
+2.9%
Gross Margin
75.42%
N/A
Market Cap
$7.36T
N/A
Market Cap/Employee
$107.20M
N/A
Employees
68,629
N/A
Net Income
$1.74B
+7.0%
EBITDA
$2.77B
-10.3%
Quarterly Fundamentals
Net Cash
$15.61B
-448.1%
Accounts Receivable
$7.76B
+9.9%
Inventory
$6.16B
+2.6%
Long Term Debt
$14.01B
N/A
Short Term Debt
$5.04B
N/A
Return on Assets
9.27%
N/A
Return on Invested Capital
18.11%
N/A
Free Cash Flow
$698.00M
+0.1%
Operating Cash Flow
$1.14B
-0.3%